M. Tomita-Yamaguchi

The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.

V. Bours, G. Franzoso, U. Siebenlist, 1992, Nature.

The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.

V. Bours, G. Franzoso, U. Siebenlist, 1993, The EMBO journal.

A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells

A. Fauci, K. Brown, L. Carlson, 1994, The Journal of experimental medicine.

Incorporation, distribution, and turnover of arachidonic acid within membrane phospholipids of B220+ T cells from autoimmune-prone MRL- lpr/lpr mice

R. Baker, M. Tomita-Yamaguchi, T. Santoro, 1990, The Journal of experimental medicine.

Constitutive turnover of inositol-containing phospholipids in B220+ T cells from autoimmune-prone MRL-lpr/lpr mice.

M. Tomita-Yamaguchi, T. Santoro, Michiyo Tomita-Yamaguchi, 1990, Journal of immunology.

Lymphocyte activation and the family of NF-kappa B transcription factor complexes.

V. Bours, G. Franzoso, U. Siebenlist, 1992, Current topics in microbiology and immunology.

Regional influences on the physical properties of T cell membranes.

C. Rubio, M. Tomita-Yamaguchi, T. Santoro, 1991, Life sciences.